T

TransMedics Group

TMDX

151.560
USD
9.24
(6.49%)
Market Closed
Volume
43,284
EPS
0
Div Yield
0
P/E
3,073
Market Cap
4,095,324,563
Related Instruments
ABT
4.220
(3.98%)
110.150 USD
B
BAX
0.190
(0.53%)
36.000 USD
BDX
-4.995
(-2.07%)
236.055 USD
BSX
1.315
(1.78%)
75.170 USD
GE
-0.380
(-0.22%)
169.750 USD
I
ILMN
-0.250
(-0.20%)
122.370 USD
SYK
5.59
(1.71%)
332.94 USD
TMO
9.03
(1.47%)
621.78 USD
Z
ZBH
-0.280
(-0.25%)
111.100 USD
News

Title: TransMedics Group

Sector: Healthcare
Industry: Medical Devices
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.